LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Opinions
  • |My Feed
  • |Events
  • |Company Directory
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/WillowWood Global Makes Strategic Investment in Reboocon Bionics, Deepening Commitment to Powered Prosthetic Technology
Company News

WillowWood Global Makes Strategic Investment in Reboocon Bionics, Deepening Commitment to Powered Prosthetic Technology

By Carl StearnsNovember 18, 2026 3 min read Premium comments

Advertisement

WillowWood Global Makes Strategic Investment in Reboocon Bionics, Deepening Commitment to Powered Prosthetic Technology
Photo courtesy of WillowWood

MOUNT STERLING, Ohio, Nov. 18, 2026 /PRNewswire/ -- WillowWood Global LLC ("WillowWood"), a designer and manufacturer of lower limb prosthetic products, today announced that it has made a strategic investment in Reboocon Bionics B.V. ("Reboocon"), the Netherlands-based developer of the Intuy® Knee, a motorized prosthetic knee. [Financial terms of the transaction were not disclosed.]

The investment builds on the strategic alliance that the two companies formed in 2023 to bring the Intuy Knee to the United States market. Through this deeper relationship, WillowWood and Reboocon intend to advance clinical research, expand access for prosthetic practitioners and their patients, and accelerate the development of next-generation powered lower limb technology.

"Powered technology represents one of the most meaningful opportunities to improve mobility for individuals with above-knee amputations," said Daniel Rubin, Co-Chief Executive Officer of WillowWood. "Since introducing the Intuy Knee to the United States market, we have seen strong adoption among prosthetic practitioners and their patients, which has validated both the technology and the strength of our partnership. This investment reflects our confidence in Reboocon's team and our shared commitment to delivering proven, clinically validated solutions to the patients our customers serve."

"WillowWood has been an exceptional partner, and this investment marks an important milestone for Reboocon," said Shiqian Wang, Founder and Chief Executive Officer of Reboocon Bionics. "Our goal has always been to help people with mobility challenges regain capability and confidence. With WillowWood's support, clinical expertise, and strong commercial presence in the United States, we are well positioned to bring the benefits of powered prosthetics to many more people."

"Following our investment in WillowWood in June 2026, we are delighted to now support the investment in Reboocon to help broaden the combined product portfolio and offer more solutions to more patients worldwide," said Marta Kowalska, Director at CVC Capital Partners.

"It is well over a decade now since I had the privilege of leading the effort that secured a dedicated reimbursement pathway for powered prosthetic knees in the United States," said Mahesh Mansukhani, Co-Chief Executive Officer of WillowWood. "That milestone opened the door for patients, but the technology of that era was only a first step. The Intuy Knee reflects everything our field has learned since then, and it is the powered knee I always hoped our industry would one day deliver. Together with Reboocon, we intend to ensure that every patient who can benefit from this technology has the opportunity to access it."

About WillowWood Global LLC

Founded in 1907 and headquartered in Mt. Sterling, Ohio, WillowWood Global is a designer and manufacturer of lower limb prosthetic products, including liners, feet, vacuum systems, and components. WillowWood serves prosthetic offices and a worldwide network of distributors, and it is guided by its mission to level the playing field. For more information, visit www.willowwood.com.

About Reboocon Bionics B.V.

Founded by Shiqian Wang, Reboocon Bionics develops wearable robotic technologies for individuals with mobility impairments. The company's flagship product, the Intuy® Knee, is a motorized prosthetic knee designed to restore powered movement for individuals with amputations at or above the knee. For more information, visit www.rbionics.com.

About CVC

CVC is a leading global private markets manager with a network of 29 office locations throughout EMEA, the Americas, and Asia, with approximately €209 billion of assets under management. CVC has seven complementary strategies across private equity, secondaries, credit and infrastructure, for which CVC funds have secured commitments of over €257 billion from some of the world's leading pension funds and other institutional investors. Funds managed or advised by CVC's private equity strategy are invested in approximately 150+ companies worldwide, which have combined annual sales of over €240 billion and employ over 660,000 people. For further information about CVC, please visit www.cvc.com.

Advertisement

Media Contact:
Hugo Rubin
Director of Marketing
WillowWood Global LLC
hugo.rubin@willowwood.com

SOURCE WillowWood Global LLC

Author

CS
Carl Stearns

Why This Matters

Two Perspectives

MBA Lens: Economic and industry impact

WillowWood Global has made a strategic investment in Reboocon Bionics, deepening their 2023 alliance for the Intuy® Knee. This move aims to accelerate market access, advance clinical research, and develop next-generation powered lower limb technology. The investment, supported by CVC Capital Partners, underscores WillowWood's confidence in Reboocon's technology and its commitment to expanding solutions for above-knee amputees, leveraging established reimbursement pathways.

  • The investment strengthens WillowWood's market position in powered prosthetics, enhancing product portfolio and distribution.
  • Strategic focus on accelerating clinical research and next-generation technology development aims to drive future market growth and competitive advantage.

PhD Lens: Clinical and outcomes impact

WillowWood Global's investment in Reboocon Bionics strengthens their collaboration on the Intuy® Knee, a motorized prosthetic knee. This partnership aims to advance clinical research and accelerate development of next-generation powered lower limb technology. The Intuy Knee is designed to restore powered movement for individuals with above-knee amputations, building on prior technological advancements and focusing on delivering clinically validated solutions for improved patient mobility.

  • The Intuy® Knee is a motorized prosthetic knee designed to restore active movement for individuals with above-knee amputations.
  • The collaboration emphasizes advancing clinical research to validate efficacy and developing future iterations of powered lower limb prosthetics.
React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

Orthopedics This Week’s mission is to connect the orthopedic community with the people, ideas, and innovations shaping the future of musculoskeletal care.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Opinions
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, opinions, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy